Milu Labs

To meet the clinical needs in women’s health, we are developing two innovative diagnostic platforms that can be used to detect major health conditions. The first is based on exosomes and functions as a new way to leverage the body’s natural cell signaling and intercellular communication pathways. Given the presence of exosomes in all body fluids, this approach provides us with a novel way to generate a “bio-fingerprint” that is predictive of future health risk for the patient. The second is based on multiomics. This is an innovative and integrated approach to diagnostics that includes the analysis of the proteome, transcriptome, epigenome and microbiome. Data from these diverse set of technologies are analyzed using advanced artificial intelligence and coalesced in a single clinical test result that empowers the healthcare provider with a clear clinical course of action.